R. Andrew Eckert
CIK: 0001210525
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 26, 2026MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
Award(A)Direct46.3K shares- - Jan 27, 2026BDX
BECTON DICKINSON & CO
Award(A)Direct1.1K shares- - Jun 16, 2025MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
Award(A)Direct231.5K shares at avg. $2.16$500K - Feb 21, 2025FTRE
Fortrea Holdings Inc.
Exercise(M)Direct7.3K shares- - Jan 28, 2025BDX
BECTON DICKINSON & CO
Award(A)Direct930 shares- - Dec 16, 2024MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
Award(A)Direct134.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | Award(A) | 46,293 | - | $0 | Direct |
| Jan 27, 2026 | BDX BECTON DICKINSON & CO | Award(A) | 1,098 | - | $0 | Direct |
| Jun 16, 2025 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | Award(A) | 231,481 | $2.16 | $499,999 | Direct |
| Feb 21, 2025 | FTRE Fortrea Holdings Inc. | Exercise(M) | 7,282 | - | - | Direct |
| Jan 28, 2025 | BDX BECTON DICKINSON & CO | Award(A) | 930 | - | $0 | Direct |
| Dec 16, 2024 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | Award(A) | 134,409 | - | $0 | Direct |
1-6 of 6 transactions
About ECKERT R ANDREW
ECKERT R ANDREW (SEC CIK 0001210525) files insider reports with the SEC as Director of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI), Director of BECTON DICKINSON & CO (BDX) and Director of Fortrea Holdings Inc. (FTRE).
Signal8 holds 7 ownership filings by ECKERT R ANDREW (1 Form 3, 6 Form 4), filed between Dec 5, 2024 and May 28, 2026. Those filings report 6 transactions, from Dec 16, 2024 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ECKERT R ANDREW's filings is in FRANKLIN LAKES, NJ.
Recent filings by ECKERT R ANDREW
- May 26, 2026: Grant or award of MRVI shares (Form 4, code A).
- Jan 27, 2026: Grant or award of BDX shares (Form 4, code A).
- Jun 16, 2025: Grant or award of MRVI shares (Form 4, code A).
- Feb 21, 2025: Option exercise of FTRE shares (Form 4, code M).
- Jan 28, 2025: Grant or award of BDX shares (Form 4, code A).
Other insiders filing for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
- Asarpota Rajesh, Chief Financial Officer
- Brust Bernd, Chief Executive Officer
- ORESHACK KURT, General Counsel
- LUCIER GREGORY T, Director
- MARKER LUKE JOSEPH, Director
- GRAY SUSANNAH, Director